What’s New

The European Medicines Agency (EMA) has granted orphan drug designation for Isarna’s lead compound ISTH0036, a LNA-modified antisense oligonucleotide, for the prevention of scarring post filtration surgery in patients with advanced glaucoma. Click here >> to learn more.